Skip to content

Yoga for Family Caregivers of Alzheimers Disease Patient

A Yoga and Compassion Meditation Program Improve Quality of Life and Self-compassion in Family Caregivers of Alzheimer's Disease Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02563483
Enrollment
46
Registered
2015-09-30
Start date
2007-09-30
Completion date
2009-11-30
Last updated
2015-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Compassion, Stress

Keywords

caregivers, anxiety, depression, yoga, meditation, stress

Brief summary

This study evaluates the effects of the practice of yoga in combination with compassion meditation on the quality of life, attention, vitality and self-compassion of family caregivers of patients with Alzheimer's disease.

Detailed description

Alzheimer's disease is a progressive brain disorder that involves the loss of reasoning, memory, language and the ability to live independently. Thus, patients who suffer from this disease often require care from another person and must adapt to ensure their health, functional capacity and safety. Caregivers have a poor quality of life due to the physical and psychological burden of caregiving. Such physical, psychological, social and financial burden can increase the risk of death. Within this scenario, techniques such as yoga and meditation have emerged as low-cost interventions that offer little or no risk to the practitioners. Yoga seeks to develop health and attention through physical postures, breathing exercises and formal meditative practices.

Interventions

BEHAVIORALyoga and compassion meditation program

25 min of physical exercise, holding each pose (stretching exercise) for an average of 1 min and 30 s; 25 min of breathing exercises and 25 min of meditation.

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* be a family caregiver of Alzheimer disease patient * age over 18 years * completed at least the primary education level * at least at the phase of stress resistance according to Lipp's Inventory of Stress Symptoms for adults

Exclusion criteria

* patient with asthma or chronic obstructive pulmonary disease (COPD) * alcohol use (more than 5 drinks per week) or use of drugs-of-abuse; * suffer from Cushing's syndrome * under treatment with topical, nasal or any form of steroids within the last 30 days * practice yoga, meditation or similar techniques

Design outcomes

Primary

MeasureTime frameDescription
change in cortisolbaseline, 8 weeksSaliva samples were collected for analysis of cortisol

Secondary

MeasureTime frameDescription
change in depressionbaseline, 8 weeksBeck Depression Inventory
change in anxietybaseline, 8 weeksBeck Anxiety Inventory
change in quality of lifebaseline, 8 weeksWHOQOL-bref (World Health Organization Quality of Life Questionnaire with 26 questions)
change in stressbaseline, 8 weeksLipp Stress Inventory
change in attentionbaseline, 8 weeksMindfulness Attention Awareness Scale
change in self-compassionbaseline, 8 weeksSelf-Compassion Scale
change in vitalitybaseline, 8 weeksSubjective Vitality Scales

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026